Doug Daniels, Ph.D.
Doug has over 20 years of experience in protein science and engineering for the discovery of both biologic and low molecular weight therapeutics. He established a protein science and structural biology group at the Broad Institute that made key discoveries to progress multiple partnered programs currently nearing clinical trials. Doug was previously a project team leader in a biologics group at Novartis, and a key contributor to one program currently in clinical trials. In his time leading groups in and collaborating across pharma, start-up, non-profit, and academic environments of the drug discovery ecosystem, Doug has experience spanning metabolic, cardiovascular, oncology, and infectious disease areas.
Doug has B.S. degrees in Chemistry and Cell & Molecular Biology from the University of Michigan. He received a Ph.D. in Biochemistry and Structural Biology from the Scripps Research Institute and was a postdoctoral fellow at Yale University.